iDNA Genomics Public Ltd Logo

iDNA Genomics Public Ltd

ISIN: CY0109800710 | Ticker: IDNA | LEI: 2549006HMJWPY9CIB812
Sector: Health CareSub-Industry: Pharmaceuticals
Country: Cyprus

About iDNA Genomics Public Ltd

Company Description

Our company operates in the booming industry of Precision Medicine and Genetic Analysis. Our focus is on developing and providing genetic analysis for Pharmacogenetics. Preventive Medicine and Genomics of Nutrition and Sports, with constant research activity through co-operation with universities in Greece and abroad.

We specialise in Genetics and fully exploit cutting-edge scientific knowledge, to provide innovative DNA analysis services that allow everybody to access their unique genetic traits, with a personalised approach.

We develop innovative and pioneering solutions by leveraging our multidimensional expertise, our scientific staff and Research & Development (R&D) department, the certified laboratories and privately owned bioinformatics analysis platform, a state-of-the-art technology and the collaboration with prestigious Universities and Research Organisations.

Year founded

2020

Served area

Cyprus

Headquarters

6 Theotokis Street, 3rd Floor, 1055 Nicosia – Cyprus

Filings & Publications

Sign up and we will give you access!

Insider Trades

Sign up and we will give you access!

Capital markets information

ISIN

CY0109800710

LEI

2549006HMJWPY9CIB812

Sector

Health Care

Industry Group

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Pharmaceuticals

Sub-Industry

Pharmaceuticals

Listed Stock Exchange

Cyprus Stock Exchange

Stock Index

CSE General Index

Contact Investor Relations department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.